UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile?

Foster, GR; D'Souza, RFC; Main, J; Crossey, M; Rosenberg, W; Murray-Lyon, IM; Hayward, C; (2003) Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile? In: (Proceedings) 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease. (pp. 646A-646A). W B SAUNDERS CO

Full text not available from this repository.
Type: Proceedings paper
Title: Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile?
Event: 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease
Location: BOSTON, MASSACHUSETTS
Dates: 24 October 2003 - 28 October 2003
Keywords: Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: http://discovery.ucl.ac.uk/id/eprint/1340569
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item